Pharmacokinetics and comparative bioavailability of two diltiazem tablet formulations in healthy volunteers

Daru

Volumn 11, Issue 1, 2003, Pages 14-18

  Dadashzadeh, Simin ^a   Zarghi, Afshin ^a   Ebrahimian, A J ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioequivalence; Diltiazem; Dissolution; Pharmacokinetics

Indexed keywords

DILTIAZEM; GENERIC DRUG;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TABLET FORMULATION;

EID: 0041861109     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. McAllister, R.G., Hamann, S.F., Blouin, R.A. (1985) Pharmakinetics of calcium entry blockers. Am. J. Cordiol. 55: 30 B-40 B.
2. Smith, M.S., Verghese, C.P., Shand, D.G., Pritchett, E.L.C. (1983) Pharmacokinetic and Pharmacodynamic effects of diltiazem. Am. J. Cardiol. 51: 1369-1374.
3. Ochs, H.R., Knuchel, M. (1984) Pharmacokinetics and absolate bioavailability of diltiazem in humans. Klin. Wochenschr. 62: 303-306.
4. Roveri, V., Gomoni, R., Mitchard, M., Larribaud, J., Blatrix, C., Thebault, J.J., Morselli, P.I., (1980) Pharmacokinetic and metabolism of diltiazem in man. Acta. Cardiol. 35: 35-45
5. Du Souich, P.N., Lery, L., Varina, F., Boucher, S., Vazina, M., Pilon, D., Spenard, J. Caille, G. (1990) Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow release capsules. Biopharm. Drug Disposit. 11: 137-147.
6. Tanigawara, Y., Yamaoka, K., Nakagawa, T., Uno, T. (1982) New Method for the evaluation of in vitro dissolution time and disintegration time. Chem. Pharm. Bull. 30: 1088-1090.
7. Stavchansky, S.A., McGinty, J.W., Biovailability in tablet technology. In: Liberman HA., Lachmen L, Schwartz JB (eds) (1989) Pharmaceutical dosage forms. Vol. 2, Dekker, New York, PP 349-564.
8. Zarghi, A., Dadashzadeh, S., Ebrahimian J.A. (2000) HPLC quantification of diltiazem in plasma from man. Pharm. Pharmacol. Commun. 6: 341-343.
9. Wagner, JG. (1979). Fundamentals of Clinical Pharmacokinetics Drug Intelligence Publications, Hamilton IL, PP: 173-201.
10. Loffreda, A., Matera, M.G., Vacca, C., Motola, G., De Santis, D., Ruggiero, A., Russo, F., Fici, F., Cantoni, V., Lampa, R., Ross, F. (1999) Bioequivalence Assessment of two different tablet formulations of diltiazem after single and repeated doses in healthy subject. Curr. Med. Res. Opin. 15: 53-61.
11. Sauter, R., Steinijans, V.W., Diletti, E., Bohm, A., Schulz, H-U (1992) Presentation of results of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 30: 233-250.